Volume 3, Issue 2 (Spring 2022)                   J Vessel Circ 2022, 3(2): 55-60 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Maghsodi V, Ahmadi J, Farahmand H, Rezvan S, Darabi M, Khorasani H R et al . Investigating Cerebrovascular Events in Brain CT Scan of COVID-19 Patients. J Vessel Circ 2022; 3 (2) :55-60
URL: http://jvessels.muq.ac.ir/article-1-235-en.html
1- Department of Radiology, School of Medicine, Ali Ibn Abi Taleb Educational and Treatment Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
2- Department of Radiology, School of Dentistry, Qom University of Medical Sciences, Qom, Iran.
3- Student Research Committee, Qom University of Medical Sciences, Qom, Iran.
Abstract:   (636 Views)
Background and Aim: The present study was conducted to investigate cerebrovascular accidents in brain computerized tomography (CT) scans of COVID-19 patients during 6 months in Ali Ibn Abi Talib Hospital in Rafsanjan City, Iran.
Materials and Methods: The present research was descriptive and correlational. The statistical population of this research included the records of all patients referred to Ali Ibn Abi Taleb Hospital from October 2019 to March 2020, whose corona test results were positive and they underwent brain imaging (computerized tomography [CT] scan). The results were obtained from the patient’s files and the census sampling method. After collecting the data, SPSS software was used to analyze the data.
Results: The results showed no relationship between the variables of age, sex, medical and drug history, disease severity, and outcome (death, recovery) with the occurrence of acute cerebral hemorrhage (P>0.05). However, a relationship is observed between the variable of medical and drug history, disease severity, and outcome (death, recovery) with the incidence of ischemia (P<0.05)
Conclusion: Considering the relationship between the patient’s medical and drug history, the severity of the patient’s disease, and the outcome (death, improvement) of the disease on the patient with the occurrence of acute ischemia, it is suggested that the results of this research be investigated more precisely.
Full-Text [PDF 682 kb]   (319 Downloads) |   |   Full-Text (HTML)  (121 Views)  
Type of Study: Research | Subject: vascular neurological diseases
Received: 2022/09/2 | Accepted: 2022/11/6 | Published: 2022/11/1

References
1. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-3. [DOI:10.1038/s41586-020-2012-7] [PMID] [PMCID] [DOI:10.1038/s41586-020-2012-7]
2. Nasiri M, Khodadadi J, Molaei S. Does vitamin D serum level the affect prognosis of COVID-19 patients? Int J Infect Dis. 2021; 107:264-7. [DOI:10.1016/j.ijid.2021.04.083] [PMID] [PMCID] [DOI:10.1016/j.ijid.2021.04.083]
3. Noori E, Vahedian M, Rezvan S, Minaei N, Tabaraii R. The proposed scoring system for hospitalization or discharge of patients with COVID-19. J Emerg Pract Trauma. 2022; 8(1):60-3. [DOI:10.34172/jept.2021.08] [DOI:10.34172/jept.2021.08]
4. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6):683-90. [DOI:10.1001/jamaneurol.2020.1127] [PMID] [PMCID] [DOI:10.1001/jamaneurol.2020.1127]
5. Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020; 382(23):2268-70. [DOI:10.1056/NEJMc2008597] [PMID] [PMCID] [DOI:10.1056/NEJMc2008597]
6. Maryam N, Javad K, Zahra H, Negar B. The probable association between blood groups and prognosis of COVID-19. Iran J Public Health. 2021; 50(4):825-30. [DOI:10.18502/ijph.v50i4.6009] [PMID] [PMCID] [DOI:10.18502/ijph.v50i4.6009]
7. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020; 87:18-22. [DOI:10.1016/j.bbi.2020.03.031] [PMID] [PMCID] [DOI:10.1016/j.bbi.2020.03.031]
8. Larson AS, Savastano L, Kadirvel R, Kallmes DF, Hassan AE, Brinjikji W. Coronavirus disease 2019 and the cerebrovascular‐cardiovascular systems: What do we know so far? J Am Heart Assoc. 2020; 9(13):e016793. [DOI:10.1161/JAHA.120.016793] [PMID] [PMCID] [DOI:10.1161/JAHA.120.016793]
9. Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020; 191:9-14. [DOI:10.1016/j.thromres.2020.04.024] [PMID] [PMCID] [DOI:10.1016/j.thromres.2020.04.024]
10. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel SC, Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: Imaging features. Radiology. 2020; 296(2):E119-20. [DOI:10.1148/radiol.2020201187] [PMID] [PMCID] [DOI:10.1148/radiol.2020201187]
11. Reichard RR, Kashani KB, Boire NA, Constantopoulos E, Guo Y, Lucchinetti CF. Neuropathology of COVID-19: A spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020; 140(1):1-6. [DOI:10.1007/s00401-020-02166-2] [PMID] [PMCID] [DOI:10.1007/s00401-020-02166-2]
12. Parsons T, Banks S, Bae C, Gelber J, Alahmadi H, Tichauer M. COVID-19-associated acute disseminated encephalomyelitis (ADEM). J Neurol. 2020; 267(10):2799-802. [DOI:10.1007/s00415-020-09951-9] [PMID] [PMCID] [DOI:10.1007/s00415-020-09951-9]
13. Hemasian H, Ansari B. The first case of COVID-19 presented with cerebral venous thrombosis: A rare and dreaded case. Rev Neurol. 2020; 176(6):521-3. [DOI:10.1016/j.neurol.2020.04.013] [PMID] [PMCID] [DOI:10.1016/j.neurol.2020.04.013]
14. Medicherla CB, Pauley RA, de Havenon A, Yaghi S, Ishida K, Torres JL. Cerebral venous sinus thrombosis in the COVID-19 pandemic. J Neuroophthalmol. 2020; 40(4):457-62. [DOI:10.1097/WNO.0000000000001122] [PMID] [DOI:10.1097/WNO.0000000000001122]
15. Koralnik IJ, Tyler KL. COVID-19: A global threat to the nervous system. Ann Neurol. 2020; 88(1):1-11. [DOI:10.1002/ana.25807] [PMID] [PMCID] [DOI:10.1002/ana.25807]
16. Hanson R, Ghosh S, Gonzalez-Gomez I, Levy M, Gilles F. Abducens length and vulnerability? Neurology. 2004; 62(1):33-6. [DOI:10.1212/WNL.62.1.33] [PMID] [DOI:10.1212/WNL.62.1.33]
17. Radmanesh A, Raz E, Zan E, Derman A, Kaminetzky M. Brain imaging use and findings in COVID-19: A single academic center experience in the epicenter of disease in the United States. AJNR Am J Neuroradiol. 2020; 41(7):1179-83. [DOI:10.3174/ajnr.A6610] [PMID] [PMCID] [DOI:10.3174/ajnr.A6610]
18. Wang D, Hu B. Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-9. [DOI:10.1001/jama.2020.1585] [PMID] [PMCID] [DOI:10.1001/jama.2020.1585]
19. Garg RK. Spectrum of neurological manifestations in COVID-19: A review. Neurol India. 2020; 68(3):560-72. [DOI:10.4103/0028-3886.289000] [PMID] [DOI:10.4103/0028-3886.289000]
20. Wang P, Lu JA, Jin Y, Zhu M, Wang L, Chen S. Statistical and network analysis of 1212 COVID-19 patients in Henan, China. Int J Infect Dis. 2020; 95:391-8. [DOI:10.1016/j.ijid.2020.04.051] [PMID] [PMCID] [DOI:10.1016/j.ijid.2020.04.051]
21. Sharifian-Dorche M, Huot P, Osherov M, Wen D, Saveriano A, Giacomini PS, et al. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci. 2020; 417:117085. [DOI:10.1016/j.jns.2020.117085] [PMID] [PMCID] [DOI:10.1016/j.jns.2020.117085]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Vessels and Circulation

Designed & Developed by : Yektaweb